Cargando…
In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease
Recently, the struggle against COVID-19 by respiratory and intensive care clinicians worldwide was punctuated by the sound of calls from a number of influential publications for an end to, as it were, improvisation and a return to principles of evidence-based medicine. The message was that managemen...
Autores principales: | Epelbaum, Oleg, Galperin, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714550/ https://www.ncbi.nlm.nih.gov/pubmed/33304409 http://dx.doi.org/10.1183/20734735.0113-2020 |
Ejemplares similares
-
Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
por: Glebov, Oleg O.
Publicado: (2020) -
Managing risk in hazardous conditions: improvisation is not enough
por: Amalberti, Rene, et al.
Publicado: (2020) -
SARS-CoV-2: The Second Wave in Europe
por: Fokas, Athanassios S, et al.
Publicado: (2021) -
SARS-CoV-2 vaccine development, access, and equity
por: Kim, Jerome H.
Publicado: (2020) -
Human-Animal Interaction and the Emergence of SARS-CoV-2
por: Hassani, Asma, et al.
Publicado: (2020)